TD Ameritrade to Offer Largest Commission-Free ETF Program with Expanded 296 ETF Lineup
Industry-leading selection of non-proprietary, low-cost ETFs from eight top ETF providers
Through the upgraded
|
|
|
This expanded, commission-free ETF lineup, most of which are new additions, are available starting tomorrow. For a complete ETF list, please visit www.amtd.com/commission-free-ETF-program.
“Clients asked us for greater choice and a wider variety of high-quality, commission-free ETFs. We’re delivering in a big way: we’ve assembled the largest list of commission-free ETFs in the business, while still retaining our open-architecture approach, with no proprietary ETFs,” said
ETFs have proven increasingly popular as more investors – from self-directed individuals to independent RIAs – seek out passive, low-cost, index-based investments to build diversified portfolios.
“For more than a decade, we’ve worked to make it easier for clients to execute their investment strategies using non-proprietary ETFs. Now we’re tripling our ETF offerings to deliver one of the most comprehensive selections of commission-free ETFs in the industry,” said
Industry-wide, the
To Learn More
To learn more about TD Ameritrade’s enhanced commission-free ETF program, please visit www.amtd.com/commission-free-ETF-program. Clients also enjoy access to an ETF Knowledge Center, advanced trading platforms, powerful tools, educational resources and the help of TD Ameritrade’s trading specialists.
About TD Ameritrade Holding Corporation
Millions of investors and independent registered investment advisors (RIAs) have turned to
About TD Ameritrade Institutional
TD Ameritrade Institutional is a leading provider of comprehensive brokerage and custody services to more than 5,000 fee-based, independent registered investment advisors and their clients. Our advanced technology platform, coupled with personal support from our dedicated service teams, allows investment advisors to run their practices more efficiently and effectively while optimizing time with clients. TD Ameritrade Institutional is a division of
Brokerage services provided by TD Ameritrade, Inc., member
Source: TD Ameritrade Holding Corporation
Important Information
Carefully consider the investment objectives, risks, charges and expenses before investing. A prospectus, obtained by calling 800-669-3900, contains this and other important information about an investment company. Read carefully before investing.
ETFs are subject to risk similar to those of their underlying securities, including, but not limited to, market, investment, sector, or industry risks, and those regarding short-selling and margin account maintenance. Some ETFs may involve international risk, currency risk, commodity risk, leverage risk, credit risk, and interest rate risk. Performance may be affected by risks associated with non-diversification, including investments in specific countries or sectors. Additional risks may also include, but are not limited to, investments in foreign securities, especially emerging markets, real estate investment trusts (REITs), fixed income, small-capitalization securities, and commodities. Each individual investor should consider these risks carefully before investing in a particular security or strategy. Investment returns will fluctuate and are subject to market volatility, so that an investor’s shares, when redeemed or sold, may be worth more or less than their original cost. Unlike mutual funds, shares of ETFs are not individually redeemable directly with the ETF. Shares are bought and sold at market price, which may be higher or lower than the net asset value (NAV).
Information provided by
ETFs purchased commission-free that are available on the
No Margin for 30 Days. Certain ETFs purchased commission free that are available on the TD Ameritrade ETF Market Center will not be immediately marginable at
Short-Term Trading Fee (Holding Period for 30 Days). ETFs available commission-free that participate in the ETF Market Center may be subject to a holding period that commences with any purchase and extends through the following THIRTY (30) calendar days. An account owner must hold all shares of an ETF position purchased for a minimum of THIRTY (30) calendar days without selling to avoid a short–term trading fee where applicable. There is no limit to the number of purchases that can be effected in the holding period. Any order to sell within THIRTY (30) calendar days of last purchase (LIFO – Last In, First Out) will cause an account owner's account to be assessed a short–term trading fee of
Neither
1
2 TD Ameritrade ETF assets under management
3
4 ETFGI, “ETFGI reports assets invested in ETFs and ETPs listed in
View source version on businesswire.com: http://www.businesswire.com/news/home/20171016005197/en/
For Advisor Media:
[email protected]
or
For Consumer Media:
[email protected]
or
For Investors:
Director, Investor Relations
[email protected]
Source:



OPINION: Why is Trump targeting his voters’ health care? | Brian Dickerson
Alignment Health Plan Receives Overall 4.5-Star Rating from Centers for Medicare and Medicaid Services
Advisor News
- Trump targets ‘retirement gap’ with new executive order
- Younger investors are engaged and advisors must adapt
- Plugging the hidden budget leaks of retirement
- Hagens Berman: Retired First Responders Sue Washington State over Rights to $3.3B Pension Funds Threatened by Lawmakers
- Financially support your adult children without risking your future
More Advisor NewsAnnuity News
- A new opportunity for advisors: Younger indexed annuity buyers
- Most employers support embedding guaranteed lifetime income options into DC Plans
- InspereX Partners with AuguStar Retirement for Strategic Expansion into Annuity Market
- FACC and DOL enter stipulation to dismiss 2020 guidance lawsuit
- Zinnia’s Zahara policy admin system adds FIA chassis to product library
More Annuity NewsHealth/Employee Benefits News
- NC Senate aims to curb Medicaid costs and allow more insight into hospital charges
- Findings in the Area of Managed Care and Specialty Pharmacy Reported from University of Utah (Socioeconomic, Demographic, and Medication Class Determinants of Medication Adherence: a Retrospective Cohort Study): Drugs and Therapies – Managed Care and Specialty Pharmacy
- New Public Health Study Findings Have Been Reported by Researchers at Louisiana State University Health Sciences Center School of Public Health (Capacity of Medicaid Providers to Implement and Sustain Evidence-Based Practices for Behavioral …): Health and Medicine – Public Health
- Rob Sand unveils water quality, public health plan
- Rob Sand unveils water quality, public health plan
More Health/Employee Benefits NewsLife Insurance News
- Convertible market dynamics and the portfolio implications for insurers
- Finalists announced for Lincoln's 2026 Best Places to Work
- Investors Heritage Promotes Anna Reynolds to Senior Vice President and General Counsel
- AM Best Affirms Credit Ratings of Old Republic International Corporation’s Subsidiaries
- Government seeks dismissal of Dean Vagnozzi’s lawsuit against SEC
More Life Insurance News